Method for determining sepsis using pro-ADM
US7972799B2 · kind B2 · utility
12Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 2009 |
| Grant date | Jul 5, 2011 |
| Priority date | — |
| Expiry date | Feb 18, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/585
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.